Powder: -20°C for 3 years | In solvent: -80°C for 1 year
MIDD0301是一种有效的正变构α5β3γ选择性GABAA 受体(GABAAR)配体,EC50为17 nM。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 1,300 | 待询 | ||
5 mg | ¥ 2,925 | 待询 | ||
10 mg | ¥ 4,387 | 待询 | ||
25 mg | ¥ 7,897 | 待询 | ||
50 mg | ¥ 11,847 | 待询 | ||
100 mg | ¥ 17,769 | 待询 | ||
200 mg | ¥ 26,654 | 待询 |
产品描述 | MIDD0301 is a potent positive allosteric α5β3γ selective GABAA receptor (GABAAR) ligand with EC50 of 17 nM. |
体内活性 | MIDD0301 did not reveal signs of general toxicity as determined by animal weight, organ weight or haematology after employing oral administration of mice twice daily with 100 mg/kg MIDD0301 mixed in peanut butter for 28 days [1]. Spleen and thymus weights were unchanged and the number of small intestine Peyer's patches was not affected in MIDD0301-treated mice.MIDD0301 treatment did not alter IgG antibody responses to dinitrophenyl following dinitrophenyl-keyhole limpet haemocyanin immunization [1]. MIDD0301 relaxed histamine-contracted guinea pig ( P < 0.05, n = 6-9) and human ( P < 0.05, n = 6-10) tracheal smooth muscle ex vivo in organ bath experiments, dilates mouse peripheral airways ex vivo in precision-cut lung-slice experiments ( P < 0.001, n = 16 airways from three mice), and alleviates bronchoconstriction in vivo in mice, as assessed by the forced-oscillation technique ( P < 0.05, n = 6 mice) [2]. |
分子量 | 414.23 |
分子式 | C19H13BrFN3O2 |
CAS No. | 2187489-08-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
MIDD0301 2187489-08-1 Membrane transporter/Ion channel Neuroscience GABA Receptor MIDD-0301 MIDD 0301 Inhibitor inhibitor inhibit